PubMed COVID-19 Clinical Care

The COVID-19 pandemic in world affected all strata of population. It started on 28 January 2020 in Wuhan province of China and since then it has been spreading all over the globe rapidly. Today there are nearly 6 million cases of COVID-19 all over

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is a threat to the global healthcare system and economic security. As of July 2020, no specific drugs or vaccines are yet

Lockdown due to the novel coronavirus disease 2019 (COVID-19) pandemic offers a unique opportunity to study the factors governing the variation in air pollution. A number of studies have investigated the cause underlying the occurrence of heavy haze

No abstract

Since the starting of the year 2020, the whole world is facing a challenge due to an outbreak of an unprecedented COVID-19 pandemic owing to a novel coronavirus. Here, a modified susceptible-infected-recovered-dead model has been used to analyze the

CONCLUSIONS AND RELEVANCE: Although exercise was able to reduce depressive symptoms among HCWs, adherence was low toward the end of the trial. Optimizing adherence to exercise programming represents an important challenge to help maintain

These S1 guidelines are an updated and expanded version of the S1 guidelines on long COVID differential diagnostic and management strategies. They summarize the state of knowledge on postviral conditions like long/post COVID at the time of writing

No abstract

CONCLUSION: In conclusion, our study showed the possible association between COVID-19 vaccination and herpesvirus reactivation. The evidence for VZV and HSV was supported by observational studies. However, regarding other herpesviruses (EBV and CMV)

CONCLUSION: The FA-PP is a sensitive assay for identifying bacteria causing VAP in patients with COVID-19, with a greater capacity to detect bacteria than the conventional method. The timely microbiological recognition offered by this panel could